Syphilis in VOICE MTN 003 Site Training. Scenario #1  A 26 year old woman presents for screening and is found to have a 1.5 cm painless ulcer. You suspect.

Slides:



Advertisements
Similar presentations
CQ Deng, PhD PPD Development Research Triangle Park, NC 27560
Advertisements

IUD Safety Research has proven IUDs to be safe and effective Research has proven IUDs to be safe and effective Elements of high quality care: appropriate.
AEs, SAEs, and EAEs – An Overview
Eric Sherman Pediatric Endo Fellow Captain, USAF, MC
Clinical Considerations
Tuberculosis in Children: Prevention Module 10C - March 2010.
An introduction to sexual health screening for Health Care Assistants
--IMPORTANT UPDATE FOR Increased Syphilis and HIV among Men Who Have Sex with Men 1 Alaska is experiencing a spike in the number of reported cases.
Diseases of the Urinary and Reproductive System Warning: Some images may be disturbing.
Adverse Events for VOICE Additional Examples. Is it an Adverse Event? Suppose a participant is found to have a grade 3 ALT after her Month 1 visit. Is.
NPW Microbiology Antenatal Presentation
Contraception/Pregnancies MTN 020. Why do we care? Participants must come off product during pregnancy and breastfeeding – Studies of dapivirine in pregnant.
Single-Dose Azithromycin versus Penicillin G Benzathine for the Treatment of Early Syphilis Jay Gargus, Department of Biological and Environmental Sciences,
Baseline Medical and Menstrual History The ins, outs, ups, and downs of collecting a relevant and complete baseline medical/menstrual history MTN 020 Training.
Continuity Clinic Coding Patient Encounters EPISODE 1 Concepts.
Genital Bleeding MTN 020 Training. Background  Genital Bleeding is common Includes menses Includes intermenstrual bleeding (IMB)  Determining whether.
Practical Management of MS in the Primary Care Office Setting Case Study 2.
Divisions of Disease Control and Laboratory Services North Dakota Department of Health September 2012.
Syphilis Dr Gregg Eloundou UHCW.
Curable versus incurable STDs. Objectives To describe the natural history and epidemiology of two curable STDs (i.e. syphilis and chlamydia) and two non-
2014 PATIENT HISTORY How would you diagnose and screen Miranda? How would you treat Miranda? Are there any additional steps you would take? Antimicrobial.
Cervical Cancer By: Kajal Haghmoradi.
The laboratory investigation of urinary tract infections
Antibody Titer Case Studies
Successful prevention of syphilis infection with azithromycin in both HIV-negative and HIV-positive individuals, San Francisco, J. D. Klausner,
MTN-028 Product Management Flow Charts Temporary Holds Permanent Discontinuations.
Cervical Sample Taker Training 2015 THE NHS CERVICAL SCREENING PROGRAMME (NHSCSP)
A 28 year old woman with two week history of vulval ulceration
Unit 6 Diagnosing TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Product Use Management MTN 020 Training. Objectives- study product tab  Identify the conditions that would require a product hold or discontinuation.
Two Men with Extensive Genital Ulcer Disease Recent Cases at the Denver Metro Health Clinic.
Sexually Transmitted Disease Epidemiology in North Dakota Chlamydia, Gonorrhea, Hepatitis C, Syphilis and HIV Lindsey VanderBusch STD/HIV/TB/Hepatitis.
Saudi Diploma in Family Medicine / 24 1 Dr. Zekeriya Aktürk Preventive Medicine and Periodic Health Examinations in Primary Care.
NYU Medicine Grand Rounds Clinical Vignette Himali Weerahandi, PGY3 March 6, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Module II: Feeding and HIV Testing for Exposed Infants This module, we will discuss: Unit 1: Infant Feeding Guidelines Unit 2: HIV Testing and Treatment.
Case Presentation Professional Practice Group Meeting Judy Gaer City clinic.
Of Tongues and Treponemes Clinical Case Studies from the Denver Metro Health Clinic.
Neurosyphilis is often considered a disease of the past. With early detection and the availability of treatment with Penicillin G, there should be no reason.
Syphilis Mark Ayitey Period 8. What is Syphilis? Syphilis is a sexually transmitted disease (STD) caused by the bacterium Treponema pallidum. It has often.
An Unusual Place For a Melanoma Salt Lake Valley Health Department STD Clinic.
Suppl Fig. 1a The clinical protocol is shown schematically.
MTN-016 TRAINING Infant HIV Testing Urvi M Parikh, Ph.D. University of Pittsburgh Pittsburgh, PA USA.
Baseline Medical and Menstrual History The ins, outs, ups, and downs of collecting a relevant and complete baseline medical/menstrual history MTN 020 Training.
Protocol Requirements for Product Holds/Discontinuations MTN-025.
1 HOPE Product Use Management: HIV Infection no rapid test(s) positive CONTINUE product. HOLD product pending confirmatory testing. PERMANENTLY DISCONTINUE.
IMPAACT 2010 Eligibility Criteria
Sexually Transmitted Infection Tutoring
Clinical Case Scenarios
IMPAACT 2010 Screening Visits
Jessica Case study.
IMPAACT 2010 Screening Visits
Topic Gonorrhea Diseases
Management of Pregnancies
IMPAACT 2010 Eligibility Criteria
The 5-Minute STD Case Study Primary Syphilis? Or?
Clinical Case Scenarios
Clinical Case Scenarios
Clinical Case Scenarios
IMPAACT 2010 Eligibility Criteria
IMPAACT 2010 Eligibility Criteria
IMPAACT 2010 Screening Visits
NSG 5003 Enthusiastic Studysnaptutorial.com
Section 22.2 Kinds of STIs Objectives
Overview.
MTN-037 Protocol Overview
MTN-034 Clinical Flow Sheets
Six Microskills for Clinical Teaching
Product Use Management: Grade 1 and Grade 2 Adverse Events
SYPHILIS A chronic disease that affects almost any organ or tissue in the body. Caused by chlamydia and gonorrhea Primary stage, secondary stage, and late.
Presentation transcript:

Syphilis in VOICE MTN 003 Site Training

Scenario #1  A 26 year old woman presents for screening and is found to have a 1.5 cm painless ulcer. You suspect syphilis on clinical grounds, but she has no known history of syphilis and is otherwise well. She is married and has 2 children

Assuming normal labs, can she be enrolled now? 1. Yes 2. No

When can she be enrolled? 1. Never 2. After she receives treatment with one dose of benzyl benzathine penicillin and the ulcer has resolved 3. After she receives treatment with three doses of benzyl benzathine penicillin and the ulcer has resolved days after she receives treatment with three doses of benzyl benzathine penicillin regardless of whether the ulcer is still present

Protocol Exclusion Criteria  Diagnosed with pelvic inflammatory disease, an STU or reproductive tract infection (RTI) requiring treatment per WHO guidelines  Note: Otherwise eligible participants may be enrolled after completing treatment and when all symptoms have resolved assuming this occurs with 56 days of screen

The participant’s RPR is negative. Does this exclude the possibility of syphilis? 1. Yes 2. No

RPR  In primary syphilis evidenced by painless genital ulcer the RPR is negative up to 30% of the time.  It can take 2-3 weeks to convert to positive RPR

Scenario #2  A 26 year old woman presents for screening and is found to have a positive RPR with a titer of 1:4. On questioning, she reports that she was diagnosed with syphilis several years ago and was treated but does not have records. She has no symptoms or signs on examination.

Assuming she is otherwise eligible, can she be enrolled right now? 1. Yes. Her pelvic exam is normal 2. Yes. She says she was treated. 3. No. You don’t have proof that she was treated.

How will you proceed? 1. Exclude from the study completely. 2. Treat with one dose of benzyl benzathine penicillin and enroll immediately 3. Treat with three doses of benzyl benzathine penicillin and enroll immediately 4. Treat with three doses of benzyl benzathine penicillinand wait for the titer to decreasebefore enrolling

 She is treated at the Screening Part 2 visit and enrolled.

When will you check titers again? 1. Within 1 week 2. 1 month 3. 3 months 4. 6 months 5. Never. She’s been treated

Checking titers: RPR  Used to quantify antibodies Not antibodies to T. pallidum but a proxy antibody (to cardiolipin-cholesterol-lecithin antigen)  Serially dilute sample

1:2

1:4

1:2 1:4 1:8

1:2 1:4 1:8 1:16

Why do we check titers?  Document adequate treatment Expect a four fold decrease within 1 year  1:16 to 1:4  1:8 to 1:2  Persistently high titer after treatment Inadequate treatment New infection